SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC

NCT04106180 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV

Interventions

DRUG: GM-CSF
DRUG: Sintilimab
RADIATION: SBRT

Sponsor

Fudan University